Incomplete Re-Expression of Neuroendocrine Progenitor/Stem Cell Markers is a Key Feature of β-Cell Dedifferentiation

Journal of Neuroendocrinology

Volumn 29, Issue 1, 2017, Pages

  Neelankal John, A ^a,b   Morahan, G ^a,b   Jiang, F X ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

mouse insulinoma 6; neuroendocrinology; cell dedifferentiation

Indexed keywords

BIOLOGICAL MARKER; DCX F PROTEIN; DCX R PROTEIN; DOUBLECORTIN; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; MESSENGER RNA; MYT1 PROTEIN; NESTIN F; NESTIN R; PCSK1 F PROTEIN; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PAX4; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; GLUCAGON; HOMEODOMAIN PROTEIN; NERVE PROTEIN; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DEDIFFERENTIATION; IN VITRO STUDY; MIN6 CELL LINE; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; BIOMARKERS; CELL DEDIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; HOMEODOMAIN PROTEINS; INSULIN; INSULIN-SECRETING CELLS; MICE; NERVE TISSUE PROTEINS; STEM CELLS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 85010874867     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12450     Document Type: Article

References (50)

1. Ferrannini E. The stunned beta cell: a brief history. Cell Metab 2010; 11: 349–352.
2. Wang Z, York NW, Nichols CG, Remedi MS. Pancreatic beta cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab 2014; 19: 872–882.
3. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 2012; 150: 1223–1234.
4. Rieck S, White P, Schug J, Fox AJ, Smirnova O, Gao N, Gupta RK, Wang ZV, Scherer PE, Keller MP, Attie AD, Kaestner KH. The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol 2009; 23: 1702–1712.
5. Huang M, Joseph JW. Assessment of the metabolic pathways associated with glucose-stimulated biphasic insulin secretion. Endocrinology 2014; 155: 1653–1666.
6. Ishihara H, Asano T, Tsukuda K, Katagiri H, Inukai K, Anai M, Kikuchi M, Yazaki Y, Miyazaki JI, Oka Y. Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia 1993; 36: 1139–1145.
7. Cheng K, Delghingaro-Augusto V, Nolan CJ, Turner N, Hallahan N, Andrikopoulos S, Gunton JE. High passage MIN6 cells have impaired insulin secretion with impaired glucose and lipid oxidation. PLoS One 2012; 7: e40868.
8. Kaminski MT, Lenzen S, Baltrusch S. Real-time analysis of intracellular glucose and calcium in pancreatic beta cells by fluorescence microscopy. Biochim Biophys Acta 2012; 1823: 1697–1707.
9. Segev H, Fishman B, Schulman R, Itskovitz-Eldor J. The expression of the class 1 glucose transporter isoforms in human embryonic stem cells, and the potential use of GLUT2 as a marker for pancreatic progenitor enrichment. Stem Cells Dev 2012; 21: 1653–1661.
10. Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001; 50: 1–11.
11. Detimary P, Gilon P, Henquin JC. Interplay between cytoplasmic Ca2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Biochem J 1998; 333(Pt 2): 269–274.
12. Shiao MS, Liao BY, Long M, Yu HT. Adaptive evolution of the insulin two-gene system in mouse. Genetics 2008; 178: 1683–1691.
13. Qin Y, Xiao L, Zhan XB, Zhou HX. Pdxl and its role in activating Ngn3 and Pax6 to induce differentiation of iPSCs into islet beta cells. Genet Mol Res 2015; 14: 8892–8900.
14. Doyle MJ, Sussel L. Nkx2.2 regulates beta-cell function in the mature islet. Diabetes 2007; 56: 1999–2007.
15. Kallas A, Pook M, Trei A, Maimets T. SOX2 Is regulated differently from NANOG and OCT4 in human embryonic stem cells during early differentiation initiated with sodium butyrate. Stem Cells Int 2014; 2014: 298163.
16. Wang S, Zhang J, Zhao A, Hipkens S, Magnuson MA, Gu G. Loss of Myt1 function partially compromises endocrine islet cell differentiation and pancreatic physiological function in the mouse. Mech Dev 2007; 124: 898–910.
17. St-Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 1997; 387: 406–409.
18. Artner I, Le Lay J, Hang Y, Elghazi L, Schisler JC, Henderson E, Sosa-Pineda B, Stein R. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 2006; 55: 297–304.
19. Tellez N, Montanya E. Gastrin induces ductal cell dedifferentiation and beta-cell neogenesis after 90% pancreatectomy. J Endocrinol 2014; 223: 67–78.
20. White MG, Al-Turaifi HR, Holliman GN, Aldibbiat A, Mahmoud A, Shaw JA. Pluripotency-associated stem cell marker expression in proliferative cell cultures derived from adult human pancreas. J Endocrinol 2011; 211: 169–176.
21. Butler PC, Meier JJ, Butler AE, Bhushan A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 2007; 3: 758–768.
22. Cinti F, Bouchi R, Kim-Muller JY, Ohmura Y, Sandoval PR, Masini M, Marselli L, Suleiman M, Ratner LE, Marchetti P, Accili D. Evidence of beta-cell dedifferentiation in human type 2 diabetes. J Clin Endocrinol Metab 2016; 101: 1044–1054.
23. Weinberg N, Ouziel-Yahalom L, Knoller S, Efrat S, Dor Y. Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic beta-cells. Diabetes 2007; 56: 1299–1304.
24. Martin D, Allagnat F, Chaffard G, Caille D, Fukuda M, Regazzi R, Abderrahmani A, Waeber G, Meda P, Maechler P, Haefliger JA. Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells. Diabetologia 2008; 51: 1429–1439.
25. Abderrahmani A, Niederhauser G, Plaisance V, Haefliger JA, Regazzi R, Waeber G. Neuronal traits are required for glucose-induced insulin secretion. FEBS Lett 2004; 565: 133–138.
26. Jiang L, Brackeva B, Stange G, Verhaeghen K, Costa O, Couillard-Despres S, Rotheneichner P, Aigner L, Van Schravendijk C, Pipeleers D, Ling Z, Gorus F, Martens GA. LC-MS/MS identification of doublecortin as abundant beta cell-selective protein discharged by damaged beta cells in vitro. J Proteomics 2013; 80: 268–280.
27. Wlodkowic D, Skommer J, Darzynkiewicz Z. Flow cytometry-based apoptosis detection. Methods Mol Biol 2009; 559: 19–32.
28. Jiang FX, Mishina Y, Baten A, Morahan G, Harrison LC. Transcriptome of pancreas-specific Bmpr1a-deleted islets links to TPH1-5-HT axis. Biol Open 2015; 4: 1016–1023.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
30. Zhang X, Yao L, Deng H, Yan J, Zhu Y, Xu W, Yao B, Weng J. Insulin requirement profiles and related factors of type 2 diabetics with insulin pump therapy. Zhonghua Yi Xue Za Zhi 2014; 94: 2417–2421.
31. Andersson SA, Olsson AH, Esguerra JL, Heimann E, Ladenvall C, Edlund A, Salehi A, Taneera J, Degerman E, Groop L, Ling C, Eliasson L. Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetes. Mol Cell Endocrinol 2012; 364: 36–45.
32. Campos C. Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med 2012; 124: 90–97.
33. Al-Majed HT, Jones PM, Persaud SJ, Sugden D, Huang GC, Amiel S, Whitehouse BJ. ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans. J Endocrinol 2004; 180: 155–166.
34. Thorens B, Wu YJ, Leahy JL, Weir GC. The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. J Clin Invest 1992; 90: 77–85.
35. Hou JC, Williams D, Vicogne J, Pessin JE. The glucose transporter 2 undergoes plasma membrane endocytosis and lysosomal degradation in a secretagogue-dependent manner. Endocrinology 2009; 150: 4056–4064.
36. Kaneto H, Miyatsuka T, Shiraiwa T, Yamamoto K, Kato K, Fujitani Y, Matsuoka TA. Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells. Curr Med Chem 2007; 14: 1745–1752.
37. Fujimoto K, Polonsky KS. Pdx1 and other factors that regulate pancreatic beta-cell survival. Diabetes Obes Metab 2009; 11(Suppl 4): 30–37.
38. Li F, Cao H, Sheng C, Sun H, Song K, Qu S. Upregulated Pdx1 and MafA contribute to beta-cell function improvement by sleeve gastrectomy. Obes Surg 2016; 26: 904–909.
39. Waeber G, Thompson N, Nicod P, Bonny C. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996; 10: 1327–1334.
40. Kaneto H, Matsuoka TA, Katakami N, Matsuhisa M. Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells. Curr Med Chem 2009; 16: 3144–3151.
41. Rashid MA, Lee S, Tak E, Lee J, Choi TG, Lee JW, Kim JB, Youn JH, Kang I, Ha J, Kim SS. Carbonyl reductase 1 protects pancreatic beta-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity. Free Radic Biol Med 2010; 49: 1522–1533.
42. Pozarowski P, Darzynkiewicz Z. Analysis of cell cycle by flow cytometry. Methods Mol Biol 2004; 281: 301–311.
43. Nelson SB, Schaffer AE, Sander M. The transcription factors Nkx6.1 and Nkx6.2 possess equivalent activities in promoting beta-cell fate specification in Pdx1+ pancreatic progenitor cells. Development 2007; 134: 2491–2500.
44. Henseleit KD, Nelson SB, Kuhlbrodt K, Hennings JC, Ericson J, Sander M. NKX6 transcription factor activity is required for alpha- and beta-cell development in the pancreas. Development 2005; 132: 3139–3149.
45. Wang S, Hecksher-Sorensen J, Xu Y, Zhao A, Dor Y, Rosenberg L, Serup P, Gu G. Myt1 and Ngn3 form a feed-forward expression loop to promote endocrine islet cell differentiation. Dev Biol 2008; 317: 531–540.
46. Wilcox CL, Terry NA, Walp ER, Lee RA, May CL. Pancreatic alpha-cell specific deletion of mouse Arx leads to alpha-cell identity loss. PLoS One 2013; 8: e66214.
47. Cain BM, Connolly K, Blum AC, Vishnuvardhan D, Marchand JE, Zhu X, Steiner DF, Beinfeld MC. Genetic inactivation of prohormone convertase (PC1) causes a reduction in cholecystokinin (CCK) levels in the hippocampus, amygdala, pons and medulla in mouse brain that correlates with the degree of colocalization of PC1 and CCK mRNA in these structures in rat brain. J Neurochem 2004; 89: 307–313.
48. Piens M, Muller M, Bodson M, Baudouin G, Plumier JC. A short upstream promoter region mediates transcriptional regulation of the mouse doublecortin gene in differentiating neurons. BMC Neurosci 2010; 11: 64.
49. Park D, Xiang AP, Mao FF, Zhang L, Di CG, Liu XM, Shao Y, Ma BF, Lee JH, Ha KS, Walton N, Lahn BT. Nestin is required for the proper self-renewal of neural stem cells. Stem Cells 2010; 28: 2162–2171.
50. Schulze T, Morsi M, Bruning D, Schumacher K, Rustenbeck I. Different responses of mouse islets and MIN6 pseudo-islets to metabolic stimulation: a note of caution. Endocrine 2016; 51: 440–447.